Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

My3D® Personalized Pelvic Reconstruction

K-Number: K212815 · 2022-07-06

Decision Date2022-07-06
Product CodeLPH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

My3D® Personalized Pelvic Reconstruction is a medical device manufactured by Onkos Surgical. It received FDA 510(k) clearance on 2022-07-06 under approval number K212815. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the My3D® Personalized Pelvic Reconstruction?

My3D® Personalized Pelvic Reconstruction is a medical device that received FDA 510(k) clearance on 2022-07-06. It is manufactured by Onkos Surgical. The 510(k) number is K212815.

When was My3D® Personalized Pelvic Reconstruction approved by the FDA?

My3D® Personalized Pelvic Reconstruction received FDA 510(k) clearance on 2022-07-06, under approval number K212815.

What company makes My3D® Personalized Pelvic Reconstruction?

My3D® Personalized Pelvic Reconstruction is manufactured by Onkos Surgical.

What is the FDA product code for My3D® Personalized Pelvic Reconstruction?

The FDA product code for My3D® Personalized Pelvic Reconstruction is LPH.

Related Clinical Trials

Related PubMed Literature

Other Devices by Onkos Surgical

Related Devices (Code: LPH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.